НүүрOPL • ASX
add
Opyl Ltd
Өмнөх хаалт
$ 0.022
Өдрийн хүрээ
$ 0.021 - $ 0.021
Жилийн хүрээ
$ 0.014 - $ 0.033
Хувьцааны нийт дүн
5.43 сая AUD
Дундаж хэмжээ
232.45 мянга
Ү/А харьцаа
-
Ногдол ашиг
-
Үндсэн валют арилжаа
ASX
Зах зээлийн мэдээ
Тухай
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Үүсгэн байгуулагдсан
2013
Вебсайт
Ажилчид
3